Breaking News Instant updates and real-time market news.

STRA

Strategic Education

$78.12 /

+5.99 (+8.30%)

08:27
07/29/21
07/29
08:27
07/29/21
08:27

Strategic Education price target lowered to $90 from $98 at BMO Capital

BMO Capital analyst Jeffrey Silber lowered the firm's price target on Strategic Education to $90 from $98 but keeps an Outperform rating on the shares. The company reported a "margin-driven" Q2 earnings beat, but while its leading indicators after summer enrollment underperformance are improving, the impact of Australia border closing could impact regional results for some time, the analyst tells investors in a research note.

  • 06

    Aug

STRA Strategic Education
$78.12 /

+5.99 (+8.30%)

05/03/21 Truist
Strategic Education price target lowered to $85 from $100 at Truist
05/03/21 BMO Capital
Strategic Education price target lowered to $98 from $130 at BMO Capital
04/30/21
Fly Intel: Top five analyst downgrades
04/30/21 BofA
Strategic Education downgraded to Neutral from Buy at BofA

TODAY'S FREE FLY STORIES

Recommendations
Citi reiterates $35 target on Plug Power after headquarter visit » 06:17
09/27/21
09/27
06:17
09/27/21
06:17
PLUG

Plug Power

$26.95 /

-0.83 (-2.99%)

Citi analyst P.J. Juvekar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLUG Plug Power
$26.95 /

-0.83 (-2.99%)

PLUG Plug Power
$26.95 /

-0.83 (-2.99%)

09/23/21 Piper Sandler
Plug Power upgraded to Overweight from Neutral at Piper Sandler
09/17/21 JPMorgan
Plug Power on track to meet 2021, 2022 billings targets, says JPMorgan
08/31/21 Wolfe Research
Plug Power initiated with an Outperform at Wolfe Research
08/09/21 Truist
Plug Power price target lowered to $29 from $42 at Truist
PLUG Plug Power
$26.95 /

-0.83 (-2.99%)

  • 27
    Jan
  • 17
    Nov
PLUG Plug Power
$26.95 /

-0.83 (-2.99%)

PLUG Plug Power
$26.95 /

-0.83 (-2.99%)

PLUG Plug Power
$26.95 /

-0.83 (-2.99%)

Recommendations
Xylem analyst day to demonstrate its strong position, says RBC Capital » 06:16
09/27/21
09/27
06:16
09/27/21
06:16
XYL

Xylem

$135.58 /

+0.46 (+0.34%)

RBC Capital analyst Deane…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XYL Xylem
$135.58 /

+0.46 (+0.34%)

08/04/21 Credit Suisse
Xylem price target raised to $110 from $97 at Credit Suisse
08/04/21 RBC Capital
Xylem price target raised to $140 from $127 at RBC Capital
08/04/21 Citi
Xylem price target raised to $131 from $117 at Citi
06/18/21 Argus
Xylem initiated with a Buy at Argus
XYL Xylem
$135.58 /

+0.46 (+0.34%)

Upgrade
Camden Property upgraded to Buy from Neutral at BofA » 06:12
09/27/21
09/27
06:12
09/27/21
06:12
CPT

Camden Property

$149.76 /

-1.43 (-0.95%)

BofA analyst Joshua…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CPT Camden Property
$149.76 /

-1.43 (-0.95%)

09/23/21
Fly Intel: Top five analyst initiations
09/23/21 Deutsche Bank
Camden Property price target raised to $160 from $132 at Deutsche Bank
09/23/21 Goldman Sachs
Camden Property initiated with a Buy at Goldman Sachs
09/01/21 Barclays
Camden Property initiated with an Overweight at Barclays
CPT Camden Property
$149.76 /

-1.43 (-0.95%)

Hot Stocks
Genetron, IMPACT Therapeutics announce partnership » 06:11
09/27/21
09/27
06:11
09/27/21
06:11
GTH

Genetron

$13.90 /

-0.29 (-2.04%)

Genetron announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTH Genetron
$13.90 /

-0.29 (-2.04%)

GTH Genetron
$13.90 /

-0.29 (-2.04%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
GTH Genetron
$13.90 /

-0.29 (-2.04%)

Hot Stocks
Aslan Pharmaceuticals reports 'positive' results from Phase 1 study of ASLAN004 » 06:10
09/27/21
09/27
06:10
09/27/21
06:10
ASLN

Aslan Pharmaceuticals

$3.25 /

+0.01 (+0.31%)

ASLAN Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASLN Aslan Pharmaceuticals
$3.25 /

+0.01 (+0.31%)

ASLN Aslan Pharmaceuticals
$3.25 /

+0.01 (+0.31%)

07/09/21 Jefferies
Aslan Pharmaceuticals initiated with a Buy at Jefferies
05/11/21 Piper Sandler
Aslan Pharmaceuticals price target lowered to $8 from $9 at Piper Sandler
03/17/21 H.C. Wainwright
Aslan Pharmaceuticals price target raised to $8 from $5 at H.C. Wainwright
03/07/21 Piper Sandler
Aslan Pharmaceuticals price target lowered to $9 from $10 at Piper Sandler
ASLN Aslan Pharmaceuticals
$3.25 /

+0.01 (+0.31%)

  • 03
    Mar
ASLN Aslan Pharmaceuticals
$3.25 /

+0.01 (+0.31%)

Hot Stocks
AstraZeneca to present data on COVID and RSV during IDWeek Virtual Conference » 06:09
09/27/21
09/27
06:09
09/27/21
06:09
AZN

AstraZeneca

$60.36 /

+0.86 (+1.45%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$60.36 /

+0.86 (+1.45%)

AZN AstraZeneca
$60.36 /

+0.86 (+1.45%)

09/23/21 Gordon Haskett
Gordon Haskett compares Incyte to Alexion before Astra buyout
09/22/21 Roth Capital
Corvus recent rally due to AstraZeneca data, says Roth Capital
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/17/21 Evercore ISI
Innate Pharma price target raised to $10 from $6 at Evercore ISI
AZN AstraZeneca
$60.36 /

+0.86 (+1.45%)

AZN AstraZeneca
$60.36 /

+0.86 (+1.45%)

AZN AstraZeneca
$60.36 /

+0.86 (+1.45%)

AZN AstraZeneca
$60.36 /

+0.86 (+1.45%)

Initiation
UnitedHealth initiated with an Outperform at SVB Leerink » 06:09
09/27/21
09/27
06:09
09/27/21
06:09
UNH

UnitedHealth

$407.15 /

-0.59 (-0.14%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNH UnitedHealth
$407.15 /

-0.59 (-0.14%)

UNH UnitedHealth
$407.15 /

-0.59 (-0.14%)

09/09/21 Cowen
UnitedHealth initiated with an Outperform at Cowen
09/08/21 Mizuho
Selloff in managed care sector overdone, says Mizuho
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
09/01/21 KeyBanc
Quest Diagnostics price target raised to $168 from $144 at KeyBanc
UNH UnitedHealth
$407.15 /

-0.59 (-0.14%)

UNH UnitedHealth
$407.15 /

-0.59 (-0.14%)

UNH UnitedHealth
$407.15 /

-0.59 (-0.14%)

UNH UnitedHealth
$407.15 /

-0.59 (-0.14%)

Periodicals
Deutsche Bank unit ignored calls to use ESG information, WSJ reports » 06:09
09/27/21
09/27
06:09
09/27/21
06:09
DB

Deutsche Bank

$12.69 /

+0.19 (+1.52%)

Fund managers at Deutsche…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DB Deutsche Bank
$12.69 /

+0.19 (+1.52%)

DB Deutsche Bank
$12.69 /

+0.19 (+1.52%)

09/17/21 JPMorgan
Deutsche Bank price target raised to EUR 13.50 from EUR 13 at JPMorgan
08/13/21
Fly Intel: Top five analyst upgrades
08/13/21 Keefe Bruyette
Deutsche Bank upgraded to Market Perform from Underperform at Keefe Bruyette
07/29/21 Credit Suisse
Deutsche Bank price target raised to EUR 10.50 from EUR 10 at Credit Suisse
DB Deutsche Bank
$12.69 /

+0.19 (+1.52%)

DB Deutsche Bank
$12.69 /

+0.19 (+1.52%)

DB Deutsche Bank
$12.69 /

+0.19 (+1.52%)

DB Deutsche Bank
$12.69 /

+0.19 (+1.52%)

Initiation
Privia Health initiated with an Outperform at SVB Leerink » 06:08
09/27/21
09/27
06:08
09/27/21
06:08
PRVA

Privia Health

$25.77 /

-0.98 (-3.66%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRVA Privia Health
$25.77 /

-0.98 (-3.66%)

PRVA Privia Health
$25.77 /

-0.98 (-3.66%)

09/09/21 Cowen
Privia Health initiated with a Market Perform at Cowen
08/10/21 Credit Suisse
Oak Street-driven dip provides opportunity in Cano, Privia, says Credit Suisse
08/09/21 Piper Sandler
Piper says Privia pullback due to market 'misinterpreting' new product news
07/14/21 Piper Sandler
Privia Health price target raised to $48 from $40 at Piper Sandler
PRVA Privia Health
$25.77 /

-0.98 (-3.66%)

  • 29
    Apr
PRVA Privia Health
$25.77 /

-0.98 (-3.66%)

PRVA Privia Health
$25.77 /

-0.98 (-3.66%)

Initiation
Acadia Healthcare initiated with an Outperform at SVB Leerink » 06:08
09/27/21
09/27
06:08
09/27/21
06:08
ACHC

Acadia Healthcare

$65.19 /

+0.05 (+0.08%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACHC Acadia Healthcare
$65.19 /

+0.05 (+0.08%)

ACHC Acadia Healthcare
$65.19 /

+0.05 (+0.08%)

09/23/21 UBS
Acadia Healthcare initiated with Buy, $81 target at UBS
09/23/21 UBS
Acadia Healthcare initiated with a Buy at UBS
09/20/21 Credit Suisse
Credit Suisse upgrades 'compelling' Acadia Healthcare on recent selloff
09/20/21 Credit Suisse
Acadia Healthcare upgraded to Outperform from Neutral at Credit Suisse
ACHC Acadia Healthcare
$65.19 /

+0.05 (+0.08%)

Hot Stocks
PyroGenesis names Andre Mainella as CFO, succeeding Ben Simo » 06:07
09/27/21
09/27
06:07
09/27/21
06:07
PYR

PyroGenesis

$3.99 /

-0.125 (-3.04%)

PyroGenesis Canada is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PYR PyroGenesis
$3.99 /

-0.125 (-3.04%)

PYR PyroGenesis
$3.99 /

-0.125 (-3.04%)

PYR PyroGenesis
$3.99 /

-0.125 (-3.04%)

PYR PyroGenesis
$3.99 /

-0.125 (-3.04%)

Initiation
Humana initiated with an Outperform at SVB Leerink » 06:07
09/27/21
09/27
06:07
09/27/21
06:07
HUM

Humana

$398.87 /

-3.07 (-0.76%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUM Humana
$398.87 /

-3.07 (-0.76%)

HUM Humana
$398.87 /

-3.07 (-0.76%)

09/24/21 Piper Sandler
1Life Healthcare price target lowered to $37 from $55.50 at Piper Sandler
09/09/21 Cowen
Humana initiated with an Outperform at Cowen
09/09/21 Barclays
Humana reinstated with an Overweight at Barclays
09/08/21 Mizuho
Selloff in managed care sector overdone, says Mizuho
HUM Humana
$398.87 /

-3.07 (-0.76%)

HUM Humana
$398.87 /

-3.07 (-0.76%)

HUM Humana
$398.87 /

-3.07 (-0.76%)

Initiation
HCA Healthcare initiated with an Outperform at SVB Leerink » 06:07
09/27/21
09/27
06:07
09/27/21
06:07
HCA

HCA Healthcare

$256.32 /

+0.79 (+0.31%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCA HCA Healthcare
$256.32 /

+0.79 (+0.31%)

HCA HCA Healthcare
$256.32 /

+0.79 (+0.31%)

09/23/21 UBS
HCA Healthcare initiated with Buy, $312 target at UBS
09/23/21 UBS
HCA Healthcare initiated with a Buy at UBS
09/09/21 Cowen
HCA's EBITDA outperformance remains underestimated, says Cowen
09/09/21 Cowen
HCA Healthcare initiated with an Outperform at Cowen
HCA HCA Healthcare
$256.32 /

+0.79 (+0.31%)

HCA HCA Healthcare
$256.32 /

+0.79 (+0.31%)

HCA HCA Healthcare
$256.32 /

+0.79 (+0.31%)

HCA HCA Healthcare
$256.32 /

+0.79 (+0.31%)

Initiation
AdaptHealth initiated with an Outperform at SVB Leerink » 06:07
09/27/21
09/27
06:07
09/27/21
06:07
AHCO

AdaptHealth

$23.01 /

-0.66 (-2.79%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AHCO AdaptHealth
$23.01 /

-0.66 (-2.79%)

AHCO AdaptHealth
$23.01 /

-0.66 (-2.79%)

07/14/21 Baird
AdaptHealth upgraded to Outperform on increasing investor confidence at Baird
07/14/21 Baird
AdaptHealth upgraded to Outperform from Neutral at Baird
07/08/21 Jefferies
Medicare home oxygen proposal positive for AdaptHealth, says Jefferies
05/07/21 Canaccord
AdaptHealth price target lowered to $44 from $50 at Canaccord
AHCO AdaptHealth
$23.01 /

-0.66 (-2.79%)

  • 06
    Jan
  • 15
    Dec
AHCO AdaptHealth
$23.01 /

-0.66 (-2.79%)

Initiation
Agilon Health initiated with an Outperform at SVB Leerink » 06:05
09/27/21
09/27
06:05
09/27/21
06:05
AGL

Agilon Health

$28.11 /

-0.455 (-1.59%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGL Agilon Health
$28.11 /

-0.455 (-1.59%)

09/09/21 Cowen
Agilon Health initiated with an Outperform at Cowen
06/03/21 Wells Fargo
Agilon Health price target raised to $44 from $38 at Wells Fargo
05/28/21 Deutsche Bank
Agilon Health price target raised to $45 from $42 at Deutsche Bank
05/10/21 William Blair
William Blair sees Agilon Health as core holding, starts at Outperform
AGL Agilon Health
$28.11 /

-0.455 (-1.59%)

  • 10
    Sep
  • 15
    Apr
AGL Agilon Health
$28.11 /

-0.455 (-1.59%)

AGL Agilon Health
$28.11 /

-0.455 (-1.59%)

Hot Stocks
Polestar to go public via merger with Gores Guggenheim » 06:05
09/27/21
09/27
06:05
09/27/21
06:05
PSNY

Polestar

/

+

, GGPI

Gores Guggenheim

$9.98 /

-0.005 (-0.05%)

Polestar Performance AB…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GGPI Gores Guggenheim
$9.98 /

-0.005 (-0.05%)

GGPI Gores Guggenheim
$9.98 /

-0.005 (-0.05%)

GGPI Gores Guggenheim
$9.98 /

-0.005 (-0.05%)

GGPI Gores Guggenheim
$9.98 /

-0.005 (-0.05%)

Initiation
Tenet Healthcare initiated with a Market Perform at SVB Leerink » 06:05
09/27/21
09/27
06:05
09/27/21
06:05
THC

Tenet Healthcare

$71.39 /

-1.36 (-1.87%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THC Tenet Healthcare
$71.39 /

-1.36 (-1.87%)

THC Tenet Healthcare
$71.39 /

-1.36 (-1.87%)

09/23/21 UBS
Tenet Healthcare initiated with a Neutral at UBS
09/23/21 UBS
Tenet Healthcare initiated with a Neutral at UBS
08/12/21 Barclays
Tenet Healthcare assumed at Overweight from Equal Weight at Barclays
07/23/21
Fly Intel: Top five analyst initiations
THC Tenet Healthcare
$71.39 /

-1.36 (-1.87%)

THC Tenet Healthcare
$71.39 /

-1.36 (-1.87%)

THC Tenet Healthcare
$71.39 /

-1.36 (-1.87%)

Initiation
Mednax initiated with a Market Perform at SVB Leerink » 06:04
09/27/21
09/27
06:04
09/27/21
06:04
MD

Mednax

$28.81 /

-0.075 (-0.26%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MD Mednax
$28.81 /

-0.075 (-0.26%)

MD Mednax
$28.81 /

-0.075 (-0.26%)

08/09/21 Truist
Mednax price target raised to $37 from $32 at Truist
06/22/21 Stifel
Mednax resumed with a Hold at Stifel
05/11/21 BMO Capital
Mednax price target raised to $35 from $27 at BMO Capital
05/10/21 Deutsche Bank
Mednax price target raised to $24 from $17.50 at Deutsche Bank
MD Mednax
$28.81 /

-0.075 (-0.26%)

Periodicals
Spotify debuts campaign to boost ad sales, WSJ reports » 06:04
09/27/21
09/27
06:04
09/27/21
06:04
SPOT

Spotify

$230.25 /

-4.325 (-1.84%)

Spotify has debuted its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPOT Spotify
$230.25 /

-4.325 (-1.84%)

SPOT Spotify
$230.25 /

-4.325 (-1.84%)

09/24/21 DZ Bank
Spotify initiated with a Sell at DZ Bank
09/13/21 Goldman Sachs
Spotify initiated with a Neutral at Goldman Sachs
09/07/21
Fly Intel: Top five analyst upgrades
09/07/21 KeyBanc
Spotify upgraded to Overweight on favorable dynamics at KeyBanc
SPOT Spotify
$230.25 /

-4.325 (-1.84%)

SPOT Spotify
$230.25 /

-4.325 (-1.84%)

SPOT Spotify
$230.25 /

-4.325 (-1.84%)

SPOT Spotify
$230.25 /

-4.325 (-1.84%)

Initiation
SPX Flow reinitiated with an Underperform at BofA » 06:04
09/27/21
09/27
06:04
09/27/21
06:04
FLOW

SPX Flow

$77.17 /

-0.63 (-0.81%)

BofA reinitiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLOW SPX Flow
$77.17 /

-0.63 (-0.81%)

FLOW SPX Flow
$77.17 /

-0.63 (-0.81%)

09/03/21 Citi
Ingersoll-Rand resumed with a Buy at Citi
07/19/21 Wolfe Research
Ingersoll-Rand, SPX Flow deal report 'credible,' says Wolfe Research
04/06/21 Barclays
SPX Flow price target raised to $58 from $54 at Barclays
03/31/21 Morgan Stanley
SPX Flow initiated with an Underweight at Morgan Stanley
FLOW SPX Flow
$77.17 /

-0.63 (-0.81%)

FLOW SPX Flow
$77.17 /

-0.63 (-0.81%)

FLOW SPX Flow
$77.17 /

-0.63 (-0.81%)

Downgrade
Northfield Bancorp downgraded to Neutral from Overweight at Piper Sandler » 06:03
09/27/21
09/27
06:03
09/27/21
06:03
NFBK

Northfield Bancorp

/

+

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFBK Northfield Bancorp
/

+

NFBK Northfield Bancorp
/

+

12/17/20 DA Davidson
DA Davidson upgraded Northfield Bancorp to Buy with multiple EPS catalysts
12/17/20 DA Davidson
Northfield Bancorp upgraded to Buy from Neutral at DA Davidson
10/01/20 Piper Sandler
Northfield Bancorp upgraded to Overweight from Neutral at Piper Sandler
NFBK Northfield Bancorp
/

+

Initiation
Amedisys initiated with a Market Perform at SVB Leerink » 06:03
09/27/21
09/27
06:03
09/27/21
06:03
AMED

Amedisys

$155.23 /

-6.48 (-4.01%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMED Amedisys
$155.23 /

-6.48 (-4.01%)

AMED Amedisys
$155.23 /

-6.48 (-4.01%)

09/23/21 UBS
Amedisys initiated with a Sell at UBS
09/23/21 UBS
Amedisys initiated with a Sell at UBS
09/09/21 Cowen
Amedisys initiated with a Market Perform at Cowen
08/11/21 Credit Suisse
Amedisys price target lowered to $250 from $330 at Credit Suisse
AMED Amedisys
$155.23 /

-6.48 (-4.01%)

AMED Amedisys
$155.23 /

-6.48 (-4.01%)

Hot Stocks
Syndax, Incyte enter collaboration and license agreement for axatilimab » 06:03
09/27/21
09/27
06:03
09/27/21
06:03
SNDX

Syndax

$18.80 /

+0.14 (+0.75%)

, INCY

Incyte

$68.99 /

-0.8 (-1.15%)

Syndax (SNDX) and Incyte…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNDX Syndax
$18.80 /

+0.14 (+0.75%)

INCY Incyte
$68.99 /

-0.8 (-1.15%)

SNDX Syndax
$18.80 /

+0.14 (+0.75%)

06/03/21 Baird
Syndax transferred with Outperform at Baird
05/25/21 Citi
Syndax initiated with a Buy at Citi
04/21/21 Baird
Syndax price target lowered to $30 from $39 at Baird
02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
INCY Incyte
$68.99 /

-0.8 (-1.15%)

09/23/21 Gordon Haskett
Gordon Haskett compares Incyte to Alexion before Astra buyout
09/23/21 RBC Capital
Incyte price target lowered to $86 from $91 at RBC Capital
09/23/21 Benchmark
Incyte's higher price for Opzelura makes up for black box, says Benchmark
09/23/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
SNDX Syndax
$18.80 /

+0.14 (+0.75%)

INCY Incyte
$68.99 /

-0.8 (-1.15%)

  • 09
    Dec
INCY Incyte
$68.99 /

-0.8 (-1.15%)

SNDX Syndax
$18.80 /

+0.14 (+0.75%)

INCY Incyte
$68.99 /

-0.8 (-1.15%)

INCY Incyte
$68.99 /

-0.8 (-1.15%)

Initiation
Anthem initiated with a Market Perform at SVB Leerink » 06:03
09/27/21
09/27
06:03
09/27/21
06:03
ANTM

Anthem

$381.46 /

+1.08 (+0.28%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANTM Anthem
$381.46 /

+1.08 (+0.28%)

ANTM Anthem
$381.46 /

+1.08 (+0.28%)

09/09/21 Cowen
Anthem can gain profitable market share, says Cowen
09/09/21 Cowen
Anthem initiated with an Outperform at Cowen
08/11/21 BTIG
Sharecare's Q2 results 'excellent,' 'impressive' level of visibility, says BTIG
07/22/21 Jefferies
Anthem should be bought on post-earnings weakness, says Jefferies
ANTM Anthem
$381.46 /

+1.08 (+0.28%)

ANTM Anthem
$381.46 /

+1.08 (+0.28%)

ANTM Anthem
$381.46 /

+1.08 (+0.28%)

Initiation
Cigna initiated with a Market Perform at SVB Leerink » 06:02
09/27/21
09/27
06:02
09/27/21
06:02
CI

Cigna

$204.00 /

+1.56 (+0.77%)

SVB Leerink analyst Whit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CI Cigna
$204.00 /

+1.56 (+0.77%)

CI Cigna
$204.00 /

+1.56 (+0.77%)

09/10/21
Fly Intel: Top five analyst downgrades
09/10/21 BofA
Cigna downgraded to Underperform from Buy at BofA
09/09/21 Cowen
Cigna initiated with a Market Perform at Cowen
09/08/21 Mizuho
Selloff in managed care sector overdone, says Mizuho
CI Cigna
$204.00 /

+1.56 (+0.77%)

CI Cigna
$204.00 /

+1.56 (+0.77%)

CI Cigna
$204.00 /

+1.56 (+0.77%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.